Counterpath Corp
CPAH
CPAH was delisted on the 26th of February, 2021.
7 hedge funds and large institutions have $769K invested in Counterpath Corp in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
12% less capital invested
Capital invested by funds: $871K → $769K (-$102K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$16 |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$4 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$16K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.02K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Fidelity Investments
Boston,
Massachusetts
| $764K | -$4.02K | -1,800 | -0.6% |
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $2K | +$16 | +7 | +0.9% |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$16K | -6,230 | Closed |
|
|
5
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$4 | +2 | New |
|
CPAH Hedge Fund Activity: Q1 2016 in Review
7 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Counterpath Corp (CPAH) for Q1 2016, worth a combined $769K — down 12% from $871K a quarter earlier.
Fund positioning in CPAH was balanced in Q1 2016: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Tower Research Capital (TRC), adding an estimated $16. The largest seller was UBS Group, exiting entirely with an estimated $16K sold.
- 7 institutional investors held Counterpath Corp (CPAH) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $769K of Counterpath Corp stock for Q1 2016, down 12% quarter-over-quarter.
- 1 fund opened new Counterpath Corp positions in Q1 2016 and 1 closed out, a net change of 0 holders.
- The largest Counterpath Corp buyer in Q1 2016 was Tower Research Capital (TRC), an estimated $16 added.
- The largest Counterpath Corp seller in Q1 2016 was UBS Group, an estimated $16K sold.
Based on aggregated 13F filings for Q1 2016.